Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested Capital

Nautilus Biotechnology (NAUT) Equity Ratio (2020 - 2026)

Nautilus Biotechnology has reported Equity Ratio over the past 7 years, most recently at 0.81 for Q1 2026.

  • Quarterly results put Equity Ratio at 0.81 for Q1 2026, down 4.87% from a year ago — trailing twelve months through Mar 2026 was 0.81 (down 4.87% YoY), and the annual figure for FY2025 was 0.82, down 4.48%.
  • Equity Ratio reached 0.81 in Q1 2026 per NAUT's latest filing, down from 0.82 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.91 in Q1 2022 and bottomed at 0.81 in Q1 2026.
  • Median Equity Ratio over the past 5 years was 0.86 (2024), compared with a mean of 0.87.
  • Peak annual rise in Equity Ratio hit 471.84% in 2022, while the deepest fall reached 8.43% in 2022.
  • Over 5 years, Equity Ratio stood at 0.9 in 2022, then fell by 3.47% to 0.87 in 2023, then dropped by 0.98% to 0.86 in 2024, then dropped by 4.48% to 0.82 in 2025, then decreased by 1.1% to 0.81 in 2026.
  • Business Quant data shows Equity Ratio for NAUT at 0.81 in Q1 2026, 0.82 in Q4 2025, and 0.84 in Q3 2025.